Business Wire

CA-XSOLLA

5.3.2024 14:01:29 CET | Business Wire | Press release

Share
Xsolla Unveils Cross-Play and Cross-Pay Strategy for Enhanced Multi-platform Monetization for Mobile Games

Xsolla, a global video game commerce company, has introduced Cross-Play and Cross-Pay, an innovative approach to mobile game monetization. In response to the evolving landscape, Xsolla’s suite of solutions enables mobile game developers to seamlessly transition their games from mobile to the web, desktop, and cloud while offering diverse monetization models out-of-the-box to power profitable direct-to-consumer sales for game developers.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240305100421/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

(Graphic: Xsolla)

As the video game industry evolves, players anticipate engaging with their favorite titles seamlessly across all platforms, form factors, and control methods. This growing expectation places Cross-Play at the forefront of modern game development strategies. Mobile game developers can now effortlessly deploy their games across Mobile, PC, Console, Cloud, and Web with Xsolla Launcher and Xsolla Cloud Gaming.

Xsolla Launcher makes it easier for developers to leverage the capabilities of desktop computing, including enhanced graphics, gameplay depth, and longer play sessions when porting mobile games to PC.

Cloud Gaming for Mobile Games, in turn, is a strategic extension of the core Xsolla Cloud Gaming solution. It enables mobile video game developers to expand cross-platform by deploying game builds to cloud platforms directly from the developer's own branded landing page, allowing them to deliver flexible monetization mechanics for mobile users.

Cross-Play experience ensures consistent and fair monetization strategy across all platforms for developers around the world. This approach ensures equal access to game content for players, thereby enhancing the overall playing experience while adhering to platform rules and guidelines. Xsolla Web Shop, a leading solution for web purchases, is a foundation for the Direct-to-Consumer strategy for mobile game developers.

Web Shops are easily customizable branded online stores fully equipped to facilitate in-game web purchases. The next iteration of the Xsolla Web Shop Solution includes innovative updates drawing on Xsolla's expertise gained from launching over 210 Web Shops and 40 of the top 100 highest-grossing mobile games worldwide. Xsolla Web Shop introduces advanced LiveOps tools, additional personalization and engagement features, and an improved user flow for seamless purchases. Alongside these enhancements, Xsolla's experts are always available to offer guidance and support by providing best practices consultation in navigating the operation and management of web shops.

“The advancements made with Cross-Play Cross-Pay have been a focus of our innovation over the past year after collaborating with numerous partners and launching over 200 web shops in 2023. This extensive real-world application with customer feedback has helped mobile game developers to efficiently market their games online by operating within the platform guidelines,” said David Stelzer, President of Xsolla. “Cross-Play Cross-Pay is our strategic innovation to meet the continuously evolving demands of the ever-changing mobile game industry. By delivering a multi-platform solution for mobile game developers, we can help them to reach more players and to grow their business.”

This comprehensive suite of Cross-Play Cross-Pay solutions empowers mobile developers to ensure their games reach the widest possible audience by establishing deep and lasting connections with players around the globe.

For more information about Xsolla Web Shop 2.0 and its features, please visit: xsolla.pro/web-shop2

For more information about Xsolla Cloud Gaming for mobile and its features, please visit: xsolla.pro/cloud-gaming

For more information about Xsolla Launcher, please visit: xsolla.pro/xsolla-launcher

About Xsolla

Xsolla is a global video game commerce company with a robust and powerful set of tools and services designed specifically for the industry. Since its founding in 2005, Xsolla has helped thousands of game developers and publishers of all sizes fund, market, launch and monetize their games globally and across multiple platforms. As an innovative leader in game commerce, Xsolla’s mission is to solve the inherent complexities of global distribution, marketing, and monetization to help our partners reach more geographies, generate more revenue, and create relationships with gamers worldwide. Headquartered and incorporated in Los Angeles, California, with offices in London, Berlin, Seoul, Beijing, Kuala Lumpur, Raleigh, Tokyo, and cities around the world, Xsolla supports major gaming titles like Valve, Twitch, Roblox, Epic Games, Take-Two, KRAFTON, Nexters, NetEase, Playstudios, Playrix, miHoYo, and more.

For additional information and to learn more, please visit: xsolla.com

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240305100421/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Biocytogen Announces Clinical Milestone with First Patient Dosed in Phase 1 Trial of IDEAYA’s First-in-Class B7H3/PTK7 Bispecific TOP1 ADC IDE03428.2.2026 01:00:00 CET | Press release

IDE034 is a B7H3/PTK7 bispecific TOP1 ADC designed to target tumor cells expressing both B7H3 and PTK7 preferentially, and is being evaluated as monotherapy and in combination with IDEAYA’s PARG inhibitor IDE161. IDEAYA has dosed the first patient in its Phase 1 trial of IDE034, initially evaluating safety, tolerability, and PK. First dosing triggers a $5 million milestone payment to Biocytogen under the companies’ option and license agreement. Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that its partner IDEAYA Biosciences, Inc. (“IDEAYA”; Nasdaq: IDYA) has dosed the first patient in IDEAYA’s Phase 1 dose-escalation/expansion clinical trial of IDE034, an investigational B7H3/PTK7 bispecific TOP1 ADC. Pursuant to the companies’ option and license agreement, first patient dosing triggers a $5 million

IQM and Real Asset Acquisition Corp. to Host Conference Call/Webcast to Discuss Proposed Transaction27.2.2026 13:00:00 CET | Press release

IQM Finland Oy, a global leader in full-stack superconducting quantum computers (“IQM”, “IQM Quantum Computers” or the “Company”), and Real Asset Acquisition Corp. (Nasdaq: RAAQ), a special purpose acquisition company (“RAAQ”), announced that they will host a conference call to discuss their recently announced business combination, including certain transaction highlights. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260227472716/en/ IQM Radiance quantum computer As previously disclosed, on February 23, 2026, IQM and RAAQ announced they have entered into a definitive business combination agreement, which will result in IQM becoming a public company and listing American Depositary Shares on one of the two leading U.S. stock exchanges. The transaction provides funding with the aim to accelerate IQM’s technology and commercial development towards fault-tolerance quantum computing, further advancing its position as a leading p

HighRadius Launches $0 Implementation Fee, $0 Subscription Fee via Outcome Based Pricing for oCFO Software27.2.2026 12:00:00 CET | Press release

HighRadius launches Office of the CFO first Outcome Based Pricing with $0 Implementation fee and $0 Subscription until Go-Live. Customers only pay a fraction of realized gains based on P&L impact. Chapter 1: Outcome Based Pricing (OBP)Introduction of OBP: HighRadius, a provider of 190+ AI agents for Order-to-Cash, Accounts Payable, Record-to-Report, and Treasury introduces Outcome Based Pricing (OBP). Three Components of OBP: Customers pay a) $0 in Implementation fees, b) $0 in Subscription fees until Go Live, c) HighRadius earns a fraction of the actual savings realized by the client. Chapter 2: US GAAP & ASC 606 ConstraintsNot Designed for Innovation: The traditional ASC 606 model requires companies to standardize and recognize revenue based on contractual obligations. For a traditional SaaS subscription, the obligation is access to software over time. AI agents are designed to deliver quantifiable, real-time Business Outcomes that do not fit the traditional accounting framework. Cha

Kioxia Appoints Yoshihiko Kawamura as Chief Financial Officer27.2.2026 09:15:00 CET | Press release

Kioxia Holdings Corporation (TOKYO:285A), a world leader in memory solutions, today announced the appointment of Yoshihiko Kawamura as Chief Financial Officer (CFO), effective April 1, 2026. Mr. Kawamura brings extensive international experience to Kioxia, having held assignments at Mitsubishi Corporation’s U.S. headquarters, served as General Manager of its Chicago office, and completed a tenure at the World Bank. At Hitachi, Ltd., he held senior leadership positions, including Chief Strategy Officer (CSO), Chief Financial Officer (CFO), and Chief Risk Management Officer (CRMO), where he was instrumental in leading the company’s management reforms. Since joining Kioxia as Executive Vice President in June 2025, Mr. Kawamura has worked closely with the executive team to advance the business through strategic capital and financial planning. Following its initial public offering on the Prime Market of the Tokyo Stock Exchange in December 2024, Kioxia is entering a new phase of growth char

DNP Invests in Rapidus to Support the Establishment of Mass Production for Next-Generation Semiconductors27.2.2026 08:18:00 CET | Press release

Will accelerate the development and mass production of EUV lithography photomasks Dai Nippon Printing Co., Ltd. (DNP, TOKYO:7912) today announced that it has participated in Rapidus Corporation’s funding round as one of the round investors. This strategic funding initiative supports Rapidus’ plan to steadily progress from its current R&D phase to mass production of 2nm (10⁻⁹ meters) logic semiconductors by 2027. Through this initiative, DNP will advance the development and mass production of EUV lithography photomasks and support Rapidus as it establishes a mass production system for 2nm & next-generation semiconductors. Background In recent years, the rise in energy consumption, in line with increased data generation, has become a challenge, driving demand for next-generation semiconductors capable of improving device performance and reducing power consumption. Next-generation semiconductors manufactured using EUV lithography enable the formation of finer patterns on silicon wafers co

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye